Vetsys Pharmaceutical
Vetsys Pharmaceutical
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) has emerged as a titan in the animal pharmaceutical sector. With a robust registered capital of 30 million RMB, we operate a massive manufacturing hub dedicated to high-efficacy veterinary drugs. Our facilities are engineered to produce a diverse portfolio including injections, powders, premixes, oral solutions, and herbal extracts.
At Vetsys, we distinguish ourselves through relentless R&D. We host an independent research institute with five specialized laboratories staffed by world-class scientists. This high-level intellectual capital allows us to pioneer new formulas in antipyretic and analgesic treatments, ensuring rapid adaptation to global animal health trends.
Quality is our cornerstone. Vetsys operates under stringent Good Manufacturing Practices (GMP). Our comprehensive quality management system oversees every production stage, from raw material sourcing to final batch testing. This commitment ensured our domestic sales surpassed USD 20 million by 2015, establishing us as a trusted partner.
The global demand for Antipyretic Analgesic Injections is witnessing an unprecedented surge, driven by the expanding livestock industry and the growing pet care sector. As global protein consumption rises, the health and productivity of cattle, swine, and poultry become paramount. Antipyretic injections are essential for managing fever caused by viral or bacterial infections, while analgesics play a critical role in pain relief during recovery or surgical procedures.
Industrial Status: Modern veterinary medicine is moving toward "Total Wellness." Manufacturers in China, like Vetsys, are now focusing on multi-modal pain management and long-acting formulations. This reduces the frequency of administration, thereby lowering animal stress and labor costs for farm owners. The industrial landscape is currently defined by a shift toward biocompatible and fast-acting ingredients.
Procurement Needs: Global procurement managers are increasingly seeking manufacturers who can provide stability in the supply chain and full regulatory compliance. In regions like Southeast Asia, Africa, and South America, there is a massive need for affordable yet high-quality injectable medications to combat tropical diseases that cause high fever in livestock.
The China Advantage: As a leading "China Best Antipyretic Analgesic Injections Manufacturer," our advantage lies in the integration of a massive raw material supply chain with advanced manufacturing technology. China’s pharmaceutical infrastructure allows for competitive pricing without compromising the rigorous standards of international GMP protocols. At Vetsys, we bridge the gap between high-end innovation and economic feasibility.
In large-scale dairy and swine farms, heat stress and respiratory infections are common. Our antipyretic injections are used to rapidly bring down body temperatures, preventing secondary complications and ensuring that feed conversion ratios (FCR) remain stable even during disease outbreaks.
For veterinary clinics catering to small animals (dogs, cats), pain management is a vital part of the service. Our analgesic solutions provide precise dosage control for post-operative recovery, ensuring animal comfort and faster healing times.
In the equine industry, maintaining joint health and managing inflammation is key. Our long-acting analgesics are formulated to treat musculoskeletal pain, allowing for better mobility and performance in sport and working horses.
As part of our long-term vision, Vetsys is committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize the impact of our operations on the environment. Our products are designed not only for efficacy but also to promote the overall well-being of animals and the ecosystem.
In addition to our strong domestic presence, Vetsys is actively exploring international expansion. Our future strategy includes strategic partnerships, research collaborations, and expanding our manufacturing capabilities to meet the increasing global demand for safe and effective animal drugs.
Our Vision: At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare.
